NCT07170046View on ClinicalTrials.gov

Predictive Value of CEA and ctDNA in Lung Cancer Recurrence

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

August 1, 2027

Study Completion Date

August 1, 2027

Conditions

Lung Carcinoma

All Listed Sponsors

lead

Guangdong Provincial People's Hospital

OTHER

NCT07170046 - Predictive Value of CEA and ctDNA in Lung Cancer Recurrence | Biotech Hunter | Biotech Hunter